The company’s strong financials and innovative collaborations, such as its partnership with AdvanCell to develop targeted cancer therapies, further enhance its appeal.

Eli Lilly and Company (NYSE:LLY) tops our list for being one of the best pharmaceutical stocks. It develops, manufactures, discovers, and sells pharmaceutical products. These goods cover ...

Cancer treatment start-up AdvanCell’s raised $171 million and Aravax raised $66 million to help grow its allergy symptom reduction products. The average deal size rose to an all-time high over ...

While biotech and medtech startups dominated total capital raised — buoyed by a $179 million raise by Harrison.ai and a $178.6 million round for cancer treatment startup AdvanCell — AI edged ...

The research program is enabled by AdvanCell’s proprietary (Lead-212) 212 Pb alpha isotope production technology along with the delivery of a first-in-field clinical platform trial to accelerate ...

A Nuclear Regulatory Commission advisory committee recently discussed how NRC can better navigate the growing market for the medical use of isotopes. At NRC’s April 8 meeting, nuclear pharmacist ...

The company also represents Advancell expandable microspheres and S-LEC BK polyvinyl acetal resins. Sekisui Specialty Chemicals is a subsidiary of the Sekisui Chemical Group, a multibillion dollar, ...

Eli Lilly and Company (NYSE:LLY) develops, manufactures, discovers, and sells pharmaceutical products. These products span oncology, diabetes, immunology ...

The company also represents Advancell expandable microspheres and S-LEC BK polyvinyl acetal resins. Sekisui Specialty Chemicals is a subsidiary of the Sekisui Chemical Group, a multibillion dollar ...

On Saturday, April 5 the Albuquerque Isotopes saw a different story with the same outcome as Friday’s game when they played the Salt Lake Bees for the fifth game of the series. It was Mariachi Night, ...